Table 2.
Demographics and clinical data (N = 211).
| Total (N = 211) | Non-adherers (n = 46) | Adherers (n = 165) | |
|---|---|---|---|
| Age | |||
| Range | 36–85 years | ||
| Median | 63 years | ||
| 36–50 years | 31 (15%) | 13 (28%) | 18 (11%) |
| 51–64 years | 80 (38%) | 19 (41%) | 61 (37%) |
| ≥65 years | 87 (41%) | 14 (30%) | 73 (44%) |
| Not provided | 13 (6%) | ||
| Marital status | |||
| Married | 167 (79%) | 37 (80%) | 130 (79%) |
| Divorced | 21 (10%) | 3 (7%) | 18 (11%) |
| Widowed | 13 (6%) | 2 (4%) | 11 (7%) |
| Single | 10 (5%) | 4 (9%) | 6 (4%) |
| Employment status | |||
| Retired | 105 (50%) | 17 (37%) | 88 (53%) |
| Paid work | 87 (41%) | 23 (14%) | 64 (39%) |
| Sick leave/unable to work | 9 (4%) | 3 (7%) | 6 (4%) |
| Unemployed | 2 (1%) | 2 (1%) | |
| Other | 8 (4%) | 3 (7%) | 5 (3%) |
| Education | |||
| ‘0’ level | 77 (37%) | 15 (33%) | 62 (38%) |
| ‘A’ level | 33 (16%) | 12 (26%) | 21 (13%) |
| College/University | 37 (18%) | 7 (15%) | 30 (18%) |
| Post-graduate | 24 (11%) | 7 (15%) | 17 (10%) |
| Other | 32 (15%) | 5 (11%) | 35 (21%) |
| Not provided | 8 (4%) | ||
| Ethnic background | |||
| White British | 207 (98%) | 46 (100%) | 161 (98%) |
| Other | 3 (2%) | 3 (2%) | |
| Diagnosis status | |||
| In breast only | 146 (69%) | 35 (76%) | 111 (67%) |
| In breast and lymph nodes | 65 (31%) | 11 (24%) | 54 (33%) |
| AET therapy | |||
| Tamoxifen | 125 (59%) | 35 (76%) | 90 (55%) |
| Aromatase | 79 (37%) | 9 (20%) | 70 (42%) |
| Inhibitors | 2 (4%) | 5 (3%) | |
| Not sure | 7 (3%) | ||
| Switched type of AET taken | 23 (11%) | 7 (14%) | 15 (9%) |
| Date started | |||
| 2009 | 5 (2%) | 1 (2%) | 4 (2%) |
| 2010 | 54 (26%) | 17 (30%) | 37 (22%) |
| 2011 | 110 (52%) | 18 (32%) | 92 (56%) |
| 2012 | 42 (20%) | 10 (22%) | 32 (19%) |
BMQ: Beliefs about Medicine Questionnaire; AET: adjuvant endocrine therapy.